Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes
Autoimmune Diseases · 2012
DOI: 10.1155/2012/321614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Autoimmune Diseases, 2012. Verfasst von Izeta Aganovic-Musinovic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genetics, Medical Faculty, University of Sarajevo, Cekalusa 90, Sarajevo, Bosnia and Herzegovina. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Autoimmune diseases occur in 3−5% of the population. Study included 30 patients with clinically diagnosed SLE and 30 healthy controls (American college of Rheumatology, 1997). SLE was diagnosed according to criteria issued in 1997 by the American College of Rheumatology (ACR). The aim of this study was to evaluate concentration values of each antigen of ENA-6 profile in SLE, to investigate possible correlation between the concentration of Sm antibodies and CIC, and to test their use as possible immunobiological markers in SLE. Furthermore, the aim of our study was to determine whether there is a correlation between Sm antibodies and CIC and SLE activity. The results revealed that all of these ENA-6 and Sm antibodies as biomarkers complement diagnoses of active SLE but their use as solo markers does not allow classifying patients with SLE. Our study has shown that based on calculations from ROC curves, Sm/RNP was clearly a very important marker for diagnosis of SLE (cut off ≥ 9.56 EU, AUC 0,942). The high incidence of Scl-70 (10%) reactivity suggests that ELISA monitoring of this antibody produces more false positive results than other multiplex assay. An important conclusion that can be drawn from the results of our study is that laboratory tests are no more effective than clinical examination for detecting disease relapse, but are helpful in the confirmation of SLE activity.
Autor:innen und Institutionen
- Center for Genetics, Medical Faculty, University of Sarajevo, Cekalusa 90, Sarajevo, Bosnia and Herzegovina.
Zitieren
APA
Aganovic-Musinovic, I., Karamehic, J., Zecevic, L., Gavrankapetanovic, F., Avdagic, N., Zaciragic, A., Jukic, T., Grcic, N., & Svrakic, S. (2012). Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes. Autoimmune Diseases. https://doi.org/10.1155/2012/321614
Vancouver
Aganovic-Musinovic I, Karamehic J, Zecevic L, Gavrankapetanovic F, Avdagic N, Zaciragic A, et al. Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes. Autoimmune Diseases. 2012. doi:10.1155/2012/321614
BibTeX
@article{AganovicMusinovic2012,
author = {Aganovic-Musinovic, Izeta and Karamehic, Jasenko and Zecevic, Lamija and Gavrankapetanovic, Faris and Avdagic, Nesina and Zaciragic, Asija and Jukic, Tomislav and Grcic, Nerima and Svrakic, Suvada},
title = {Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes},
journal = {Autoimmune Diseases},
year = {2012},
doi = {10.1155/2012/321614}
}
EUVIMED